Clinical Trials Browser

Phase 2/3 × OTHER × Carcinoma, Non-Small-Cell Lung × Clear all

NCT07597070 2026-05-19

UNIFIER

Phase 2/3 Not yet recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04702009 2026-04-29

Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung

NCT03637816 2026-04-15

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Phase 2/3 Active not recruiting

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07149649 2026-03-27

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2/3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07440290 2026-02-27

DETERMINE

Phase 2/3 Not yet recruiting

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07131319 2026-02-02

SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07213375 2026-01-07

DEXTER

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05768178 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07076693 2025-07-22

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07034326 2025-06-24

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05255302 2025-04-01

DIAL

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05807893 2024-11-13

SUPER BRAIN

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04322617 2024-06-04

ATHENA

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02448992 2023-05-01

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

Phase 2/3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04942275 2022-09-19

PEGASUS

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04968002 2021-07-20

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02416739 2020-01-27

Anticancer Activity of Nicotinamide on Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01631357 2019-11-05

CIK

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT00775307 2019-09-24

Adjuvant Pazopanib in Stage I NSCLC

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung

NCT02759783 2019-08-21

CORE

Phase 2/3 Unknown

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT01407822 2018-09-11

EMERGING

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02284139 2018-04-23

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Phase 2/3 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03074864 2017-03-09

TREND

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00775385 2017-03-03

TASTE

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung

NCT01319669 2017-03-03

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02802540 2016-08-31

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Phase 2/3 Unknown

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung

NCT02780778 2016-05-23

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02338011 2015-01-26

EGFR

Phase 2/3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01761747 2014-12-23

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Phase 2/3 Terminated

3 enrolled 9 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01528488 2013-11-05

Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung

NCT01802021 2013-03-01

QSYQT

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00002930 2013-01-18

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Phase 2/3 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms

NCT01481259 2012-07-03

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00752115 2011-09-07

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung

NCT00312819 2010-08-31

Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung